Urinary ascorbic acid—HPLC determination and application as a noninvasive biomarker of hepatic response
Identifieur interne : 004195 ( Main/Exploration ); précédent : 004194; suivant : 004196Urinary ascorbic acid—HPLC determination and application as a noninvasive biomarker of hepatic response
Auteurs : Mark L. Poon [Canada] ; I. Chu [Canada] ; P. Lecavalier [Canada] ; A. Bergman [Suède] ; D. C. Villeneuve [Canada]Source :
- Journal of Biochemical Toxicology [ 0887-2082 ] ; 1994-12.
English descriptors
- KwdEn :
Abstract
A high‐performance liquid chromatograph (HPLC) procedure has been developed for the determination of rat urinary ascorbic acid, a major metabolite cf the hepatic glucuronic acid pathway. The presence of EDTA and HC1 effectively inhibited degradation of ascorbic acid during the collection of urine specimens. The reliability of the procedure was demonstrated by its high recovery (90%), specificity (characteristic absorption maximum and discrimination from iso‐ascorbic acid), and reproducibility (2–3% coefficient of variation). The usefulness of this assay as an indicator of hepatic response was demonstrated in preliminary experiments where increases in urinary ascorbic acid excretion were detected in male rats treated with PCB 126 (3,3′,4,4′,5‐pentachloro‐biphenyl) or PCB 105 (2,3,3′,4,4′‐pentachlorobi‐phenyl). The HPLC measurement also showed that the two PCB congeners differed markedly in their potency in stimulating urinary ascorbic acid excretion. For example, 10 μ/kg bw/day of PCB 126 was sufficient to cause a fourfold increase in urinary ascorbic excretion while 5000 μ/kg bw/day of PCB 105 was required for a sevenfold increase. In response to the administration of PCB 105 or PCB 126, urinary ascorbic acid appeared to increase to the same extent as increases in hepatic ethoxyresorufin O‐deethylase (EROD) and UDP‐glucuronosyltransferase (UGT) activities, and to a much higher extent than changes in liver weight and hematological and serum clinical chemical parameters. The sensitivity and specificity, the ease in obtaining timed specimens, and the noninvasive nature make this assay a useful biomarker of hepatic response in dose‐finding and various acute and chronic studies.
Url:
DOI: 10.1002/jbt.2570090604
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000455
- to stream Istex, to step Curation: 000455
- to stream Istex, to step Checkpoint: 001B22
- to stream Main, to step Merge: 004952
- to stream Main, to step Curation: 004195
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Urinary ascorbic acid—HPLC determination and application as a noninvasive biomarker of hepatic response</title><author><name sortKey="Poon, Mark L" sort="Poon, Mark L" uniqKey="Poon M" first="Mark L." last="Poon">Mark L. Poon</name></author><author><name sortKey="Chu, I" sort="Chu, I" uniqKey="Chu I" first="I." last="Chu">I. Chu</name></author><author><name sortKey="Lecavalier, P" sort="Lecavalier, P" uniqKey="Lecavalier P" first="P." last="Lecavalier">P. Lecavalier</name></author><author><name sortKey="Bergman, A" sort="Bergman, A" uniqKey="Bergman A" first="A." last="Bergman">A. Bergman</name></author><author><name sortKey="Villeneuve, D C" sort="Villeneuve, D C" uniqKey="Villeneuve D" first="D. C." last="Villeneuve">D. C. Villeneuve</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B28595F01E6FDBB9E8288F3A733476A8C5863CCD</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1002/jbt.2570090604</idno><idno type="url">https://api-v5.istex.fr/document/B28595F01E6FDBB9E8288F3A733476A8C5863CCD/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000455</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000455</idno><idno type="wicri:Area/Istex/Curation">000455</idno><idno type="wicri:Area/Istex/Checkpoint">001B22</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001B22</idno><idno type="wicri:doubleKey">0887-2082:1994:Poon M:urinary:ascorbic:acid</idno><idno type="wicri:Area/Main/Merge">004952</idno><idno type="wicri:Area/Main/Curation">004195</idno><idno type="wicri:Area/Main/Exploration">004195</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Urinary ascorbic acid—HPLC determination and application as a noninvasive biomarker of hepatic response</title><author><name sortKey="Poon, Mark L" sort="Poon, Mark L" uniqKey="Poon M" first="Mark L." last="Poon">Mark L. Poon</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Environmental and Occupational Toxicology Division, Health Canada, Ottawa</wicri:regionArea><wicri:noRegion>Ottawa</wicri:noRegion></affiliation><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Room 315, Environmental Health Centre, Tunney's Pasture, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Chu, I" sort="Chu, I" uniqKey="Chu I" first="I." last="Chu">I. Chu</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Environmental and Occupational Toxicology Division, Health Canada, Ottawa</wicri:regionArea><wicri:noRegion>Ottawa</wicri:noRegion></affiliation></author><author><name sortKey="Lecavalier, P" sort="Lecavalier, P" uniqKey="Lecavalier P" first="P." last="Lecavalier">P. Lecavalier</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Environmental and Occupational Toxicology Division, Health Canada, Ottawa</wicri:regionArea><wicri:noRegion>Ottawa</wicri:noRegion></affiliation></author><author><name sortKey="Bergman, A" sort="Bergman, A" uniqKey="Bergman A" first="A." last="Bergman">A. Bergman</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Wallenberg Laboratory, University of Stockholm, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Villeneuve, D C" sort="Villeneuve, D C" uniqKey="Villeneuve D" first="D. C." last="Villeneuve">D. C. Villeneuve</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Environmental and Occupational Toxicology Division, Health Canada, Ottawa</wicri:regionArea><wicri:noRegion>Ottawa</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Biochemical Toxicology</title><title level="j" type="abbrev">J. Biochem. Toxicol.</title><idno type="ISSN">0887-2082</idno><idno type="eISSN">1522-7146</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Weinheim</pubPlace><date type="published" when="1994-12">1994-12</date><biblScope unit="volume">9</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="297">297</biblScope><biblScope unit="page" to="304">304</biblScope></imprint><idno type="ISSN">0887-2082</idno></series><idno type="istex">B28595F01E6FDBB9E8288F3A733476A8C5863CCD</idno><idno type="DOI">10.1002/jbt.2570090604</idno><idno type="ArticleID">JBT2570090604</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0887-2082</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ascorbic Acid</term><term>Biomarker</term><term>Polychlorinated Biphenyls</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A high‐performance liquid chromatograph (HPLC) procedure has been developed for the determination of rat urinary ascorbic acid, a major metabolite cf the hepatic glucuronic acid pathway. The presence of EDTA and HC1 effectively inhibited degradation of ascorbic acid during the collection of urine specimens. The reliability of the procedure was demonstrated by its high recovery (90%), specificity (characteristic absorption maximum and discrimination from iso‐ascorbic acid), and reproducibility (2–3% coefficient of variation). The usefulness of this assay as an indicator of hepatic response was demonstrated in preliminary experiments where increases in urinary ascorbic acid excretion were detected in male rats treated with PCB 126 (3,3′,4,4′,5‐pentachloro‐biphenyl) or PCB 105 (2,3,3′,4,4′‐pentachlorobi‐phenyl). The HPLC measurement also showed that the two PCB congeners differed markedly in their potency in stimulating urinary ascorbic acid excretion. For example, 10 μ/kg bw/day of PCB 126 was sufficient to cause a fourfold increase in urinary ascorbic excretion while 5000 μ/kg bw/day of PCB 105 was required for a sevenfold increase. In response to the administration of PCB 105 or PCB 126, urinary ascorbic acid appeared to increase to the same extent as increases in hepatic ethoxyresorufin O‐deethylase (EROD) and UDP‐glucuronosyltransferase (UGT) activities, and to a much higher extent than changes in liver weight and hematological and serum clinical chemical parameters. The sensitivity and specificity, the ease in obtaining timed specimens, and the noninvasive nature make this assay a useful biomarker of hepatic response in dose‐finding and various acute and chronic studies.</div></front></TEI><affiliations><list><country><li>Canada</li><li>Suède</li></country><region><li>Svealand</li></region><settlement><li>Stockholm</li></settlement></list><tree><country name="Canada"><noRegion><name sortKey="Poon, Mark L" sort="Poon, Mark L" uniqKey="Poon M" first="Mark L." last="Poon">Mark L. Poon</name></noRegion><name sortKey="Chu, I" sort="Chu, I" uniqKey="Chu I" first="I." last="Chu">I. Chu</name><name sortKey="Lecavalier, P" sort="Lecavalier, P" uniqKey="Lecavalier P" first="P." last="Lecavalier">P. Lecavalier</name><name sortKey="Poon, Mark L" sort="Poon, Mark L" uniqKey="Poon M" first="Mark L." last="Poon">Mark L. Poon</name><name sortKey="Villeneuve, D C" sort="Villeneuve, D C" uniqKey="Villeneuve D" first="D. C." last="Villeneuve">D. C. Villeneuve</name></country><country name="Suède"><region name="Svealand"><name sortKey="Bergman, A" sort="Bergman, A" uniqKey="Bergman A" first="A." last="Bergman">A. Bergman</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004195 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004195 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B28595F01E6FDBB9E8288F3A733476A8C5863CCD
|texte= Urinary ascorbic acid—HPLC determination and application as a noninvasive biomarker of hepatic response
}}
| This area was generated with Dilib version V0.6.29. |  |